BNTX
BioNTech SE
99.10$
+0.6%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | +1,426.1% | -60.4% | -96.1% | +110.9% | |
| – | +108.8% | +54.2% | +14.2% | +94.3% | +64.0% | +48.7% | +62.5% | +23.4% | |
| – | +29.3% | +295.2% | +6.3% | +192.5% | +15.7% | -52.7% | +96.3% | +5.3% | |
| – | -73.1% | +265.5% | -14.6% | +4,776.8% | – | – | – | – | |
| – | – | – | – | – | – | +23.4% | -78.1% | -57.7% | |
| – | +17.5% | +4.8% | +20.1% | +80.3% | +135.9% | +94.2% | -35.9% | -62.8% | |
| – | +27.8% | +15.0% | +87.6% | +291.0% | -93.8% | +19,601.1% | -70.1% | +13.9% | |
| – | – | – | – | – | – | -100.0% | – | – | |
| – | – | +3.8% | -100.0% | – | – | -25.1% | -100.0% | – | |
| – | – | +130.0% | +1,685.1% | -147.1% | -11.4% | -32.1% | +14.5% | +10.9% | |
| – | – | +5.0% | +133.4% | -89.5% | -1,606.7% | -45.1% | -94.1% | +10.7% | |
| – | – | -55.1% | +542.3% | -30.2% | +2,424.8% | -118.2% | – | – | |
| – | – | – | – | – | +1,696.1% | -64.7% | -105.2% | – |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.